Related Experiment Video
Updated: Nov 29, 2025
13:04
Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
Published on: March 18, 2015
12.4K
Human iPS Cell-derived Tissue Engineered Vascular Graft: Recent Advances and Future Directions
Xiangyu Shi1,2, Lile He3, Shang-Min Zhang4
1Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China.
Stem Cell Reviews and Reports
|November 24, 2020
Summary
Human induced pluripotent stem cells (hiPSCs) offer a scalable source for vascular cells, overcoming limitations of primary cells in tissue engineered vascular grafts (TEVGs). Research shows promising progress in hiPSC-TEVGs, though challenges remain.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Stem Cell Biology
Background:
- Tissue engineered vascular grafts (TEVGs) using primary cells face limitations: limited supply, donor variability, and immune rejection.
- Human induced pluripotent stem cells (hiPSCs) provide a renewable and scalable cell source for vascular tissue engineering.
Purpose of the Study:
- To review the progress in generating TEVGs using hiPSC-derived cells.
- To summarize current challenges in hiPSC-based vascular tissue engineering.
- To outline future research directions for hiPSC-TEVGs.
Main Methods:
- Review of current literature on hiPSC differentiation into vascular cells.
- Analysis of TEVG fabrication techniques using hiPSC-derived cells.
- Assessment of mechanical properties and implantability of hiPSC-TEVGs.
Main Results:
- hiPSC-derived cells can be generated in large quantities with comparable quality to primary cells.
- TEVGs constructed with hiPSC-derived cells demonstrate significant mechanical strength and implantability.
- Significant progress has been made in the field of hiPSC-TEVG research.
Conclusions:
- hiPSC-TEVGs represent a promising advancement in vascular interventional therapy.
- Further research is needed to address challenges in hiPSC differentiation and vascular tissue engineering technologies.
- Optimization of production and clinical application strategies is crucial for future success.
